Gene Therapy Breakthrough: Navigating Parkinson’s Circuitry for Lasting Relief

Retrograde AAV selectively targets D1-MSNs and rescues parkinsonian symptoms with chemogenetic modulation
Retrograde AAV selectively targets D1-MSNs and rescues parkinsonian symptoms with chemogenetic modulation
Read Entire Article

© 2024 Thiratti. All rights reserved.